Outcomes of extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB) cases in Estonia, Germany, Italy and the Russian Federation
| Treatment success | Died | Default | Failure | Transferred | Total patients completing treatment | |
| XDR-TB# | 22 (39.3) | 14 (25.0) | 8 (14.3) | 12 (21.4) | 0 (0.0) | 56 |
| MDR-TB resistant to all first-line drugs¶ | 123 (53.7) | 35 (15.3) | 39 (17.0) | 29 (12.7) | 3 (1.3) | 229 |
| Other MDR-TB+ | 42 (66.7) | 8 (12.7) | 10 (15.9) | 3 (4.8) | 0 (0.0) | 63 |
| Total | 187 (53.7) | 57 (16.4) | 57 (16.4) | 44 (12.6) | 3 (0.9) | 348 |
Data are presented as n (%) or n. #: resistance to at least rifampin and isoniazid (definition of MDR-TB) in addition to any fluoroquinolone, and at least one of the three injectable anti-TB drugs (capreomycin, kanamycin and amikacin); ¶: cases resistant to isoniazid, rifampicin ethambutol, streptomycin and, when tested, pyrazinamide; +: cases susceptible to at least one first-line anti-TB drug. Default and transferred cases included in this table were removed from the analysis presented in the text.